Sales at CVS’s retail unit rose 77% to $22.75 billion, helped by strength in its pharmacies as well as its front-end stores that sell over the counter consumer health products.
The company said its pharmacies benefited as consumers refilled prescriptions early as they prepared for the COVID-19 pandemic.
Excluding items, CVS earned $1.91 per share, beating estimates of $1.63 per share, according to IBES data from Refinitiv.
Sales rose 8.3% to $66.76 billion, beating estimates of $64.10 billion.
The company maintained its 2020 adjusted profit forecast.
Net income rose to $2.01 billion, or $1.53 per share, in the quarter ended March 31, from $1.42 billion, or $1.09 per share, a year earlier.